
Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday
By
Darya Rudz
The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage.